Global Neuromodulation Devices and Implantable Infusion Pumps Market Insights and Forecast to 2027

Global Neuromodulation Devices and Implantable Infusion Pumps Market Insights and Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Neuromodulation Devices and Implantable Infusion Pumps Product Introduction
1.2 Market by Type
1.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth Rate by Type
1.4.2 Spinal Cord Stimulation
1.4.3 Deep Brain Stimulation
1.2.4 Sacral Nerve Stimulation
1.2.5 Vagal Nerve Stimulation
1.2.6 Gastric Stimulation
1.2.7 Transcranial Magnetic Stimulation
1.2.8 Transcutaneous Electrical Stimulation
1.2.9 Other
1.3 Market by Application
1.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth Rate by Application
1.3.2 Parkinson's Disease
1.3.3 Epilepsy
1.3.4 Pain
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Estimates and Forecasts 2016-2027
2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Estimates and Forecasts 2016-2027
2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Neuromodulation Devices and Implantable Infusion Pumps Regions by Sales
2.4.1 Global Top Neuromodulation Devices and Implantable Infusion Pumps Regions by Sales (2016-2021)
2.4.2 Global Top Neuromodulation Devices and Implantable Infusion Pumps Regions by Sales (2022-2027)
2.5 Global Top Neuromodulation Devices and Implantable Infusion Pumps Regions by Revenue
2.5.1 Global Top Neuromodulation Devices and Implantable Infusion Pumps Regions by Revenue (2016-2021)
2.5.2 Global Top Neuromodulation Devices and Implantable Infusion Pumps Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Manufacturers
3.1.1 Global Top Neuromodulation Devices and Implantable Infusion Pumps Manufacturers by Sales (2016-2021)
3.1.2 Global Top Neuromodulation Devices and Implantable Infusion Pumps Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Neuromodulation Devices and Implantable Infusion Pumps Sales in 2020
3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Manufacturers
3.2.1 Global Top Neuromodulation Devices and Implantable Infusion Pumps Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Neuromodulation Devices and Implantable Infusion Pumps Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Neuromodulation Devices and Implantable Infusion Pumps Revenue in 2020
3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Neuromodulation Devices and Implantable Infusion Pumps Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type
4.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Historical Sales by Type (2016-2021)
4.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Forecasted Sales by Type (2022-2027)
4.1.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2016-2027)
4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type
4.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Historical Revenue by Type (2016-2021)
4.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Forecasted Revenue by Type (2022-2027)
4.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2016-2027)
4.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Type
4.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Type (2016-2021)
4.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application
5.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Historical Sales by Application (2016-2021)
5.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Forecasted Sales by Application (2022-2027)
5.1.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2016-2027)
5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application
5.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Historical Revenue by Application (2016-2021)
5.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Forecasted Revenue by Application (2022-2027)
5.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (2016-2027)
5.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Application
5.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Application (2016-2021)
5.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Price Forecast by Application (2022-2027)
6 North America
6.1 North America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Type
6.1.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2016-2027)
6.1.2 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2016-2027)
6.2 North America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Application
6.2.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2016-2027)
6.2.2 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2016-2027)
6.3 North America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
6.3.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2016-2027)
6.3.2 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size by Type
7.1.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2017-2027)
7.1.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2017-2027)
7.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size by Application
7.2.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2017-2027)
7.2.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2017-2027)
7.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
7.3.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2017-2027)
7.3.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size by Type
8.1.1 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2018-2027)
8.1.2 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2018-2027)
8.2 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size by Application
8.2.1 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2018-2027)
8.2.2 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2018-2027)
8.3 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size by Region
8.3.1 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2018-2027)
8.3.2 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Type
9.1.1 Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2019-2027)
9.1.2 Latin America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2019-2027)
9.2 Latin America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Application
9.2.1 Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2019-2027)
9.2.2 Latin America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2019-2027)
9.3 Latin America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
9.3.1 Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2019-2027)
9.3.2 Latin America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Size by Type
6.1.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2016-2027)
6.1.2 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2016-2027)
6.2 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Size by Application
6.2.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2016-2027)
6.2.2 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2016-2027)
6.3 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
6.3.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2016-2027)
6.3.2 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E
11 Company Profiles
11.1 Medtronic
11.1.1 Medtronic Corporation Information
11.1.2 Medtronic Overview
11.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Description
11.1.5 Medtronic Related Developments
11.2 Boston Scientific Corporation
11.2.1 Boston Scientific Corporation Corporation Information
11.2.2 Boston Scientific Corporation Overview
11.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Description
11.2.5 Boston Scientific Corporation Related Developments
11.3 Abbott
11.3.1 Abbott Corporation Information
11.3.2 Abbott Overview
11.3.3 Abbott Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Abbott Neuromodulation Devices and Implantable Infusion Pumps Product Description
11.3.5 Abbott Related Developments
11.4 Synapse Biomedical
11.4.1 Synapse Biomedical Corporation Information
11.4.2 Synapse Biomedical Overview
11.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Description
11.4.5 Synapse Biomedical Related Developments
11.5 Nevro Corporation
11.5.1 Nevro Corporation Corporation Information
11.5.2 Nevro Corporation Overview
11.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Description
11.5.5 Nevro Corporation Related Developments
11.6 Neuropace
11.6.1 Neuropace Corporation Information
11.6.2 Neuropace Overview
11.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product Description
11.6.5 Neuropace Related Developments
11.7 Cyberonics
11.7.1 Cyberonics Corporation Information
11.7.2 Cyberonics Overview
11.7.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product Description
11.7.5 Cyberonics Related Developments
11.8 Autonomic Technologies
11.8.1 Autonomic Technologies Corporation Information
11.8.2 Autonomic Technologies Overview
11.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product Description
11.8.5 Autonomic Technologies Related Developments
11.9 Avery Biomedical
11.9.1 Avery Biomedical Corporation Information
11.9.2 Avery Biomedical Overview
11.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Description
11.9.5 Avery Biomedical Related Developments
11.10 Greatbatch Medical
11.10.1 Greatbatch Medical Corporation Information
11.10.2 Greatbatch Medical Overview
11.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product Description
11.10.5 Greatbatch Medical Related Developments
11.1 Medtronic
11.1.1 Medtronic Corporation Information
11.1.2 Medtronic Overview
11.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Description
11.1.5 Medtronic Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Neuromodulation Devices and Implantable Infusion Pumps Value Chain Analysis
12.2 Neuromodulation Devices and Implantable Infusion Pumps Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Neuromodulation Devices and Implantable Infusion Pumps Production Mode & Process
12.4 Neuromodulation Devices and Implantable Infusion Pumps Sales and Marketing
12.4.1 Neuromodulation Devices and Implantable Infusion Pumps Sales Channels
12.4.2 Neuromodulation Devices and Implantable Infusion Pumps Distributors
12.5 Neuromodulation Devices and Implantable Infusion Pumps Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Neuromodulation Devices and Implantable Infusion Pumps Industry Trends
13.2 Neuromodulation Devices and Implantable Infusion Pumps Market Drivers
13.3 Neuromodulation Devices and Implantable Infusion Pumps Market Challenges
13.4 Neuromodulation Devices and Implantable Infusion Pumps Market Restraints
14 Key Findings in The Global Neuromodulation Devices and Implantable Infusion Pumps Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Spinal Cord Stimulation
Table 3. Major Manufacturers of Deep Brain Stimulation
Table 4. Major Manufacturers of Sacral Nerve Stimulation
Table 5. Major Manufacturers of Vagal Nerve Stimulation
Table 6. Major Manufacturers of Gastric Stimulation
Table 7. Major Manufacturers of Transcranial Magnetic Stimulation
Table 8. Major Manufacturers of Transcutaneous Electrical Stimulation
Table 9. Major Manufacturers of Other
Table 10. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 11. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 12. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2016-2021) & (K Units)
Table 13. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2016-2021)
Table 14. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2016-2021) & (K Units)
Table 15. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2022-2027)
Table 16. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2016-2021) & (US$ Million)
Table 17. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region (2016-2021)
Table 18. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2022-2027) & (US$ Million)
Table 19. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region (2022-2027)
Table 20. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Manufacturers (2016-2021) & (K Units)
Table 21. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Manufacturers (2016-2021)
Table 22. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 23. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Manufacturers (2016-2021)
Table 24. Neuromodulation Devices and Implantable Infusion Pumps Price by Manufacturers 2016-2021 (USD/Unit)
Table 25. Global Neuromodulation Devices and Implantable Infusion Pumps Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Neuromodulation Devices and Implantable Infusion Pumps by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuromodulation Devices and Implantable Infusion Pumps as of 2020)
Table 27. Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base Distribution and Headquarters
Table 28. Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Product Offered
Table 29. Date of Manufacturers Enter into Neuromodulation Devices and Implantable Infusion Pumps Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2016-2021) & (K Units)
Table 32. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2022-2027) & (K Units)
Table 33. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Type (2016-2021)
Table 34. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Type (2022-2027)
Table 35. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2016-2021) & (US$ Million)
Table 36. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2022-2027) & (US$ Million)
Table 37. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Type (2016-2021)
Table 38. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Type (2022-2027)
Table 39. Neuromodulation Devices and Implantable Infusion Pumps Price by Type (2016-2021) & (USD/Unit)
Table 40. Global Neuromodulation Devices and Implantable Infusion Pumps Price Forecast by Type (2022-2027) & (USD/Unit)
Table 41. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2016-2021) & (K Units)
Table 42. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2022-2027) & (K Units)
Table 43. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Application (2016-2021)
Table 44. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Application (2022-2027)
Table 45. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2016-2021) & (US$ Million)
Table 46. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2022-2027) & (US$ Million)
Table 47. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Application (2016-2021)
Table 48. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Application (2022-2027)
Table 49. Neuromodulation Devices and Implantable Infusion Pumps Price by Application (2016-2021) & (USD/Unit)
Table 50. Global Neuromodulation Devices and Implantable Infusion Pumps Price Forecast by Application (2022-2027) & (USD/Unit)
Table 51. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2016-2021) & (K Units)
Table 52. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2022-2027) & (K Units)
Table 53. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2016-2021) & (US$ Million)
Table 54. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2022-2027) & (US$ Million)
Table 55. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2016-2021) & (K Units)
Table 56. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2022-2027) & (K Units)
Table 57. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2016-2021) & (US$ Million)
Table 58. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2022-2027) & (US$ Million)
Table 59. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2016-2021) & (K Units)
Table 60. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2022-2027) & (K Units)
Table 61. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2016-2021) & (US$ Million)
Table 62. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2022-2027) & (US$ Million)
Table 63. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2016-2021) & (K Units)
Table 64. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2022-2027) & (K Units)
Table 65. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2016-2021) & (US$ Million)
Table 66. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2022-2027) & (US$ Million)
Table 67. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2016-2021) & (K Units)
Table 68. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2022-2027) & (K Units)
Table 69. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2016-2021) & (US$ Million)
Table 70. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2022-2027) & (US$ Million)
Table 71. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2016-2021) & (K Units)
Table 72. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2022-2027) & (K Units)
Table 73. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2016-2021) & (US$ Million)
Table 74. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2022-2027) & (US$ Million)
Table 75. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2016-2021) & (K Units)
Table 76. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2022-2027) & (K Units)
Table 77. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2016-2021) & (US$ Million)
Table 78. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2022-2027) & (US$ Million)
Table 79. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2016-2021) & (K Units)
Table 80. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2022-2027) & (K Units)
Table 81. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2016-2021) & (US$ Million)
Table 82. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2022-2027) & (US$ Million)
Table 83. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2016-2021) & (K Units)
Table 84. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2022-2027) & (K Units)
Table 85. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2016-2021) & (US$ Million)
Table 86. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2022-2027) & (US$ Million)
Table 87. Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2016-2021) & (K Units)
Table 88. Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2022-2027) & (K Units)
Table 89. Latin America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2016-2021) & (US$ Million)
Table 90. Latin America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2022-2027) & (US$ Million)
Table 91. Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2016-2021) & (K Units)
Table 92. Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2022-2027) & (K Units)
Table 93. Latin America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2016-2021) & (US$ Million)
Table 94. Latin America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2022-2027) & (US$ Million)
Table 95. Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2016-2021) & (K Units)
Table 96. Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2022-2027) & (K Units)
Table 97. Latin America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2016-2021) & (US$ Million)
Table 98. Latin America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2022-2027) & (US$ Million)
Table 99. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2016-2021) & (K Units)
Table 100. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2022-2027) & (K Units)
Table 101. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2016-2021) & (US$ Million)
Table 102. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2022-2027) & (US$ Million)
Table 103. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2016-2021) & (K Units)
Table 104. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2022-2027) & (K Units)
Table 105. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2016-2021) & (US$ Million)
Table 106. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2022-2027) & (US$ Million)
Table 107. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2016-2021) & (K Units)
Table 108. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2022-2027) & (K Units)
Table 109. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2016-2021) & (US$ Million)
Table 110. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2022-2027) & (US$ Million)
Table 111. Medtronic Corporation Information
Table 112. Medtronic Description and Major Businesses
Table 113. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 114. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product
Table 115. Medtronic Recent Developments
Table 116. Boston Scientific Corporation Corporation Information
Table 117. Boston Scientific Corporation Description and Major Businesses
Table 118. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 119. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product
Table 120. Boston Scientific Corporation Recent Developments
Table 121. Abbott Corporation Information
Table 122. Abbott Description and Major Businesses
Table 123. Abbott Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 124. Abbott Neuromodulation Devices and Implantable Infusion Pumps Product
Table 125. Abbott Recent Developments
Table 126. Synapse Biomedical Corporation Information
Table 127. Synapse Biomedical Description and Major Businesses
Table 128. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 129. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product
Table 130. Synapse Biomedical Recent Developments
Table 131. Nevro Corporation Corporation Information
Table 132. Nevro Corporation Description and Major Businesses
Table 133. Nevro Corporation Neuromodulation Devices and I

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs